Who founded AccurKardia?

AccurKardia was founded by Juan C Jimenez, Juan C. Jimenez, Tony M Kuttiachen in 2019.

How much funding has AccurKardia raised?

AccurKardia has disclosed $4.1M raised across 1 round.

Where is AccurKardia headquartered?

AccurKardia is headquartered in New York, US.

AccurKardia

New York, US · Founded 2019 · Delaware corporation

AccurKardia develops AI-based technology for cardiac monitoring and ECG interpretation, serving clinicians and healthcare providers. It operates in the cardiology-focused medtech and digital health space.

AI & Machine Learning Digital Health Medical Devices

Founders & leadership

AccurKardia was founded in 2019 by Juan C Jimenez, Juan C. Jimenez, and Tony M Kuttiachen.

Juan C JimenezCo-founder

Juan C. JimenezinCo-Founder & CEO

Tony M KuttiacheninCo-Founder & GM Cardiac Monitoring

Dr. Naveed RazviinChief Medical Officer

Moin HussainiinChief Product Officer

Mohamed Sadeq AliinCo-Founder & COO

John FoxinCo-Founder & Sr. Advisor

Naveen SrinivasinCo-Founder & Sr. Advisor

Reported raises · per SEC filings

Form D private placements

$4.1M disclosed across 1 round · 2022

▶$4.1MraisedJun 2023 · 41 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Mohamed Sadeq AliDirector
John FoxDirector
Naveen SrinivasDirector
Juan C JimenezExecutive Officer, Director

Offering amount: $4.1M
Amount sold: $4.1M
First sale: Aug 2022
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 9

by search overlap

Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

AliveCor6 shared keywordsAliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.

Aviary Health5 shared keywordsAviary Health provides virtual and hybrid clinical programs — including cardiac rehabilitation, pulmonary rehabilitation, and chronic care management — combining AI-powered workflows with clinical teams. It serves hospitals and health systems, delivering end-to-end support for complex service lines.

Biotricity5 shared keywordsBiotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.

Cardiosense5 shared keywordsCardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management. Its FDA De Novo-cleared platform supports pressure-guided heart failure management for clinicians across hospital and home care settings.

SymKardia5 shared keywordsSymKardia develops a selective cardiac neuromodulation therapy to treat cardiac arrhythmias such as atrial fibrillation, targeting the nervous system rather than only cardiac tissue. It is a clinical-stage cardiovascular medical device company running pre-clinical and clinical research programs.

Bioworld4 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

ComKardia4 shared keywordsComKardia is developing an AI-powered decision-support platform for coronary artery disease and PCI planning that builds a patient-specific digital twin to help interventional cardiologists plan stent selection, sizing, and placement within the cath lab workflow. The company targets interventional cardiology and plans to distribute its imaging-guided PCI software through a licensing and SaaS model.

Digital3 shared keywordsDigital.Health is a clinician-curated discovery platform where clinicians, health systems, and consumers find, compare, and select digital health solutions. It offers structured company and product listings that feed its comparison engine, recommendation system, and AI-enabled search for buyers in active evaluation.

Companies competing with AccurKardia for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does AccurKardia do?: AccurKardia develops AI-based technology for cardiac monitoring and ECG interpretation, serving clinicians and healthcare providers. It operates in the cardiology-focused medtech and digital health space.
Who founded AccurKardia?: AccurKardia was founded by Juan C Jimenez, Juan C. Jimenez, Tony M Kuttiachen in 2019.
How much funding has AccurKardia raised?: AccurKardia has disclosed $4.1M raised across 1 round.
Where is AccurKardia headquartered?: AccurKardia is headquartered in New York, US.